companydata.dkCAND.PHARM. POVL M. ASSENS FOND: Financial statements 2025
CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000. The solvency ratio was 98.1%. The company had 56 employees in the financial year.
- Gross Profit
- 0 kr.
- Profit/Loss
- 13,153,000 kr.
- Equity
- 128,614,000 kr.
- Total Assets
- 131,058,000 kr.
- Employees
- 56
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 13.2 mio. | 128.6 mio. | 56 |
| 2024 | 0 | - | 11.8 mio. | 117.5 mio. | 52 |
| 2023 | 0 | 0 | 7.1 mio. | 107.1 mio. | 53 |
| 2022 | - | - | -3.3 mio. | 101.7 mio. | 47 |
| 2021 | 0 | 0 | 7.3 mio. | 106.1 mio. | 41 |
Find more companies like CAND.PHARM. POVL M. ASSENS FOND
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK 11,790,112.
About CAND.PHARM. POVL M. ASSENS FOND
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.